Singapore has emerged as a global hub for clinical research, with over 10,000 ongoing clinical trials. These trials offer patients access to the latest experimental treatments and provide valuable insights into the development of new medical therapies.
Why Singapore?
Singapore's strong healthcare infrastructure, skilled workforce, and supportive government policies have made it an attractive location for clinical trials. Additionally, the country's diverse population provides a wide range of potential participants for research studies.
Clinical trials in Singapore cover a wide range of medical specialties, including:
Patients interested in participating in a clinical trial can learn more through:
Innoverse refers to the convergence of innovation and the universe of clinical trials. This concept encompasses the use of cutting-edge technologies and novel approaches to enhance the efficiency and effectiveness of clinical research.
Table 1: Top 5 Therapeutic Areas for Clinical Trials in Singapore
Rank | Therapeutic Area | Number of Trials |
---|---|---|
1 | Oncology | 2,514 |
2 | Cardiovascular Disease | 1,870 |
3 | Diabetes | 764 |
4 | Infectious Diseases | 632 |
5 | Mental Health | 578 |
Table 2: Top 5 Sponsoring Organizations for Clinical Trials in Singapore
Rank | Organization | Number of Trials |
---|---|---|
1 | National Cancer Centre Singapore | 420 |
2 | National University of Singapore | 389 |
3 | Singapore Health Services | 354 |
4 | Agency for Science, Technology and Research | 298 |
5 | Duke-NUS Medical School | 247 |
Table 3: Top 5 Countries of Origin for Clinical Trial Participants in Singapore
Rank | Country | Percentage |
---|---|---|
1 | Singapore | 45% |
2 | Malaysia | 22% |
3 | China | 18% |
4 | Indonesia | 6% |
5 | India | 5% |
Table 4: Timeline for a Typical Clinical Trial
Phase | Purpose | Estimated Duration |
---|---|---|
Phase I | Safety and Tolerability | 6-12 months |
Phase II | Efficacy and Dosage | 1-3 years |
Phase III | Large-Scale Efficacy and Safety | 3-5 years |
Phase IV | Post-Marketing Surveillance | Indefinite |
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-10-25 21:21:08 UTC
2024-10-26 11:27:20 UTC
2024-10-27 01:45:07 UTC
2024-10-27 15:27:58 UTC
2024-10-28 21:20:16 UTC
2024-10-29 13:37:09 UTC
2024-10-30 06:03:06 UTC
2024-10-31 15:06:30 UTC
2025-01-06 06:15:39 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:37 UTC
2025-01-06 06:15:37 UTC
2025-01-06 06:15:33 UTC
2025-01-06 06:15:33 UTC